TrialBreast cancer research : BCR2009

Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy.

Christos Markopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.